EUCTR2006-001911-31-AT进行中（未招募）1 期
Metformin-Wirkung am Ovar bei PCOS (MAO-Studie) - eine Pilotstudie
niversitätsfrauenklinik Innsbruck0 个研究点目标入组 20 人开始时间: 2007年2月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •hyperandrogenaemia
- •age: 18-40 years
- •pregnancy excluded
- •no renal or liver diseases
- •written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •diabetes I + II
- •taking drugs, which could falsify the results or could lead to unwanted effects of metformin
- •side effects like lactate acidosis
研究者
相似试验
已完成
不适用
Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT01474967Hormozgan University of Medical Sciences50
已完成
4 期
Trial With Metformin in Women With Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT02280057Herning Hospital56
Unknown
早期 1 期
Vaginal Administration of Metformin in PCOS Patients.PCOSNCT02026869Assiut University200
Unknown
不适用
Effects of Metformin on Metabolic and Reproductive Outcomes in Chinese PCOS PatientsPolycystic Ovary SyndromeMetforminNCT05463627RenJi Hospital1,440
Unknown
不适用
Efficacy of Metformin in PCOS: Metabolic and Hormonal FactorsPolycystic Ovary SyndromeNCT00317928Aarhus University Hospital Skejby50